Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC
- Status
- TERMINATED
- Phase
- PHASE1
Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Gemox as First and Second Line Therapy in Unknown Primary Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL)
- Status
- COMPLETED
- Phase
- PHASE2
S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2